ClinicalTrials.gg
Not yet recruitingNCT07792460Updated Aug 28, 2026

Facial Exercise and Daily Habit Modification Program for Skin Quality and Wrinkle Severity in Middle-Aged Women

An interventional study of Facial Exercise and Daily Habit Modification Program in Facail Skin Aging, sponsored by University of Zakho. Not yet recruiting at 1 site in Iraq. Open to female participants aged 45 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by University of Zakho · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
45 Years to 50 Years
Sex
Female
01

Study summary

This randomized controlled trial will evaluate the effectiveness of a 12-week program combining facial muscle exercises and daily habit modification for improving skin quality and reducing wrinkle severity in middle-aged women. Participants will be randomly allocated to an intervention group receiving the structured program or to a control group maintaining their usual routine. Skin-related outcomes will be assessed at baseline and after 12 weeks using standardized objective measurements.

02

Conditions studied

  • Facail Skin Aging
03

In context

Lead sponsor

University of Zakho is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

nclusion Criteria: Female participants aged 45-50 years. Willing and able to participate in the 12-week intervention program. Willing to maintain their usual skincare routine and comply with the study procedures. Able to provide .

Exclusion Criteria:

Current smoking. Facial aesthetic procedures such as botulinum toxin injections, dermal fillers, laser treatment, chemical peels, or similar procedures within the predefined period before enrollment. Current dermatological disease or skin condition that may affect facial skin measurements. Uncontrolled chronic medical conditions that may influence skin health or participation in the intervention. Planned initiation of new skincare treatments, cosmetic products, or aesthetic procedures during the 12-week study period. Inability to perform the facial exercise program safely or comply with the study procedures

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
204 participants (estimated)

Study arms

  • Experimental
    intervention group

    Participants in the intervention group will complete a 12-week structured facial exercise program combined with daily habit modification related to skin health

    Behavioral: Facial Exercise and Daily Habit Modification Program

  • No intervention
    control group

    Participants in the control group will maintain their usual daily routine and will not receive the structured facial exercise or daily habit modification program during the 12-week study period

Interventions

  • BehavioralFacial Exercise and Daily Habit Modification Program

    A 12-week structured program consisting of facial muscle exercises combined with daily habit modification related to skin health

06

What researchers measure

Primary outcomes

  1. Change in Wrinkle-Severity Reduction Index

    Change in the mean bilateral crow's feet wrinkle depth (mm) from baseline to week 12, measured using Antera 3D. Three measurements will be obtained from each side, and the mean of the six measurements will be used as the participant-level value. Lower values indicate reduced wrinkle depth

    Time frame: Baseline to 12 weeks

07

Study locations

1 site
  • Fitness Centers and Gyms in Duhok
    Duhok, Duhok Governorate 42001, Iraq
08

References and documents

Individual participant data

Plan to share: No — Individual participant data are not planned to be shared. Only aggregated, de-identified study results will be reported

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07792460
Lead sponsor
University of Zakho
Responsible party
Dalshad Mohamed Abdulrehman (principal investigator, University of Zakho) — Principal investigator
First posted
Aug 28, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Nov 24, 2026 (estimated)
Completion
Nov 24, 2026 (estimated)
Last update
Aug 28, 2026

Study contacts

dalshad m abdulrehman, ph.D .
Contact
dlshadm079@gmail.com
009647501891419

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion